SURG:NASDAQSurgePays, Inc. Analysis
Data as of 2026-09-01 - not real-time
$0.17
Latest Price
9/10Risk
Risk Level: High
Executive Summary
SurgePays, Inc. is priced at $0.1670 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 47.8% over the past 30 days. RSI sits at 34.3, which reads as approaching oversold, and MACD momentum is bearish. Price has been bracketed by support at $0.1460 and resistance at $0.4300.
Valuation screens as undervalued: a P/E of 3.3 sits below the sector average of 16.1. Sell-side targets cluster 1995.8% above the current quote. Revenue is growing at 40.7% on a -47.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 175.1%, a beta of 0.88 and a maximum drawdown of 94.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Valuation screens as undervalued: a P/E of 3.3 sits below the sector average of 16.1. Sell-side targets cluster 1995.8% above the current quote. Revenue is growing at 40.7% on a -47.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 175.1%, a beta of 0.88 and a maximum drawdown of 94.5%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.
Top Market Events
・SurgePays NASDAQ:SURG returned to positive net income in Q2 2026, marking its sixth consecutive quarter of revenue...First Half Revenue Grew 45.7% to $32.19 Million While G&A Declined 9.3% Sixth Consecutive Quarter of Sequential Revenue...Hosted on MSN17dSurgePays stock skyrockets following return to Q2 profitability and strong revenue growthShares of...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 0.87
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 3.3 versus sector average of 16.1
- Trading below the 200-day average of 0.87
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 3.3 versus sector average of 16.1
- Negative profit margin of -47.9%
- Analyst targets imply +1995.8% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth40.70%
Profit Margin-47.89%
P/E Ratio3.3
ROA-122.77%
P/B Ratio-0.2
Op. Cash Flow$-15391765
Free Cash Flow$-624030
Industry P/E16.1
Technical Analysis
TrendBearish
RSI34.3
Support$0.15
Resistance$0.43
MA 20$0.23
MA 50$0.29
MA 200$0.87
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79
Valuation
Target Price$3.50
Upside/Downside1995.81%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.88
Volatility175.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.